Haohai sees red-hot demand for $304m HK listing
Shanghai Haohai Biological Technology’s HK$2.36bn ($304m) IPO received a rousing reception allowing bookbuilding to wrap up sooner than planned as booming demand led to the shares pricing at the top of the range.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts